2014 Archived Content

High-Content Analysis User Group Meetings: 

TUESDAY, February 18, 2014

Molecular Devices8:00am - 12:00pm Molecular Devices User Group Meeting 

Want to improve your high content imaging experience? Then join influential and respected scientists at our annual users meeting at CHI’s 11th Annual High-Content Analysis Conference. Speakers will discuss how they are targeting unique applications and accelerating their discoveries with the ImageXpress® Systems. Attendees are encouraged to share their experiences regarding key applications, tips and tricks, as well as discuss challenging assays.

Reservations: Seating is limited, so please pre-register HERE to reserve your seat.

Molecular Devices will introduce the latest ImageXpress Micro XLS System with following exciting features:

- Flexible light source options that fit your application needs

- Increased imaging speed to >50,000 wells per day

- Automatic time-lapse analysis simplifying live-cell assays

- Intuitive software enabling basic to advanced applications


8:00 – 8:30

Check in

8:30 – 8:40

Opening Remarks

8:40 – 9:10

Using High Content Analysis for Monitoring Cell Specification in the Development
of Human iPSC-derived Cells

Coby Carlson, Ph.D., Cellular Dynamics International 

9:10 – 9:40  

Adapting Human iPS Cells and their Differentiated Derivatives for
High-Content Imaging

Dhruv Sareen, Ph.D., Cedars-Sinai Medical Center 

9:40 – 10:10  

Pushing the Boundaries of High Content Imaging 

Grischa Chandy, Senior Product Manger, Cellular Imaging, Molecular Devices LLC 

10:10 – 10:25  


10:25 – 10:55  

Using the ImageXpress Micro XLS for High Content Screening with
1536-well Plates

Doug Quackenbush, Genomics Institute of the Novartis Research Foundation 

10:55 – 11:25  

Genedata Screener Integration with MDCStore allows for High Content Analysis in High Throughput 

John Tupy, Genedata 

11:25 – 11:30  

Closing Remarks



GE Healthcare Logo1:30pm - 5:30pmGE Healthcare User Group Meeting

You are invited to GE Healthcare’s User Group Meeting 

Join leading scientists at GE Healthcare Life Sciences users meeting at CHI’s 11th Annual High-Content Analysis Conference to find out about the latest applications and troubleshooting tips in Cellular imaging and analyses areas. Presenters will include experts from academia and industry using IN Cell Analyzer systems. GE Healthcare is committed to developing and promoting opportunities in the areas of cellular sciences. Similar to our previous symposia, this exclusive event will focus on bringing together key thought leaders in cellular research to further explore new tools from high-content analysis.

GE Healthcare's High Content Analysis (HCA) platform comprises a choice of two high-performance versatile imaging instruments, IN Cell Analyzer 2200 and IN Cell Analyzer 6000, to advance cellular understanding in applications such as drug discovery research. Both instruments are designed to give you a head start in HCA through features that allow you to get as much as possible from the available signal and to select the image quality, sensitivity, and speed that you need for your applications.

As a tool provider GE Life Sciences has a flexible range of offering so you can make a decision based on your research needs not the limitation of the products.  

IN Cell Analyzer 2200: Super-fast, sensitive, and flexible wide-field cell imaging system for a broad range of high-content assays.

IN Cell Analyzer 6000: High-performance laser-based confocal imaging system designed for the most demanding high content assays and screens.


Scientific Presentations 


1:30-2:00 pm

What’s new in the area of high content analysis and automated imaging 

Dan Collins, Application Scientist. GE Healthcare Life Sciences

2:00-2:30 pm

In vitro expansion of hematopoietic stem and progenitorcells,

Michelle Arkin, PhD, Assoc. Dir., Biology, Small Molecule Discovery, UCSF

How to develop a high-throughput screen, using the IN Cell Analyzer 2000, to identify small molecules and a culture medium that strongly expands hematopoietic stem cells and progenitor cells in vitro. Our goal is to use such cells to improve stem-cell transplantation and to explore the biology of hematopoiesis.

2:30-2:45 pm


2:45-3:15 pm

A flexible high-throughput imaging and analysis platform built around the GE IN Cell Analyzer 2200 

Tianxiao Sun PhD, Associate Principal Scientist , Merck

3:15-3:45 pm

High content analysis drives screening of complex biology 

Sumon Datta , Scientist, Novartis

3:45-4:15 pm


4:15-4:45 pm

High content analysis platforms to support culture systems 

Patrick Jones, PhD, Staff Scientist, Genzyme

4:45-5:15 pm

Translation of human stem cells to the clinic and as assay tools 

Thorsten Gorba, PhD, Director, CNS Assay Screening & Development, StemCells, Inc.

5:15-5:30 pm



Reservations:Please pre-register by sending an email to gefas.support@ge.com

PerkinElmer NEW 20091:30pm - 5:30pm PerkinElmer User Group Meeting 

Join the PerkinElmer user group and hear how your peers are using high content imaging to analyze disease models with greater physiological relevance, such as primary cells, live cells and cells cultured in 3D, in order to develop new drugs and therapies.

Find out how PerkinElmer HCS systems, like the Operetta® High Content Imaging System and Opera® High Content Screening System, are being used to gain a better understanding of disease processes and to translate those findings from in vitro to in vivo. Learn how software such as the Columbus™ Image Data Storage and Analysis System, Volocity® 3D Image Analysis Software and TIBCO Spotfire® Visualization and Analysis Platform can enable you to develop robust phenotypic fingerprinting and combine data from different sources to discover new correlations.


Natural Product Screening for Clinical Drug Development
Sue Mooberry Ph.D., University of Texas Health Science Center at San Antonio 

Talk Title to be Announced
Steve Katchur, GlaxoSmithKline 

Analysis of Neurons in Primary Cells, iPSC-Neurons, Tissue
Karsten Kottig, Evotec AG 

Fast Forward – High Content Phenotypic Screening Accelerated
Jacob Tesdorpf, Ph.D., PerkinElmer

Talk Title to be Announced
Jörn Hopke Sanofi 

Reservations:There is no charge to attend the forum, but space is limited and pre-registration is required. For more information and to register, please visit www.perkinelmer.com/HCA2014.